NO921697L - Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav - Google Patents
Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse deravInfo
- Publication number
- NO921697L NO921697L NO92921697A NO921697A NO921697L NO 921697 L NO921697 L NO 921697L NO 92921697 A NO92921697 A NO 92921697A NO 921697 A NO921697 A NO 921697A NO 921697 L NO921697 L NO 921697L
- Authority
- NO
- Norway
- Prior art keywords
- trfp
- protein
- peptide
- isolated
- house dust
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43156589A | 1989-11-03 | 1989-11-03 | |
PCT/US1990/006548 WO1991006571A1 (en) | 1989-11-03 | 1990-11-02 | A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
NO921697D0 NO921697D0 (no) | 1992-04-30 |
NO921697L true NO921697L (no) | 1992-07-03 |
Family
ID=23712496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92921697A NO921697L (no) | 1989-11-03 | 1992-04-30 | Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0500785B1 (da) |
JP (1) | JP3251012B2 (da) |
AT (1) | ATE216401T1 (da) |
AU (1) | AU650249B2 (da) |
CA (1) | CA2073045C (da) |
DE (1) | DE69033949T2 (da) |
DK (1) | DK0500785T3 (da) |
ES (1) | ES2174822T3 (da) |
FI (1) | FI921979A0 (da) |
NO (1) | NO921697L (da) |
WO (1) | WO1991006571A1 (da) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6019972A (en) | 1989-11-03 | 2000-02-01 | Immulogic Pharmaceutical Corporation | Peptides of human T cell reactive feline protein (TRFP) |
US6120769A (en) * | 1989-11-03 | 2000-09-19 | Immulogic Pharmaceutical Corporation | Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
US5328991A (en) * | 1989-11-03 | 1994-07-12 | Immulogic Pharmaceutical Corp. | Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes |
US5547669A (en) | 1989-11-03 | 1996-08-20 | Immulogic Pharma Corp | Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I |
US7288256B1 (en) | 1991-10-16 | 2007-10-30 | Merck Patent Gmbh | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
KR100260342B1 (ko) * | 1991-10-16 | 2000-07-01 | 스타세이 엘. 첸링 | 더마토파고이드로 부터 유래된 알레르겐의 t세포 에피토프 |
NZ299122A (en) * | 1991-10-16 | 2005-02-25 | Immulogic Pharma Corp | Detecting and treating allergies using peptides with T-cell stimulating activity |
IL105153A (en) * | 1992-03-25 | 1999-12-22 | Immulogic Pharma Corp | Therapeutic compositions comprising peptides derived from human t cell reactive feline protein |
US5968526A (en) * | 1994-04-14 | 1999-10-19 | Immulogic Pharamaceutical Corporation | T cell epitopes of the major allergens from Dermatophagoides (house dust mite) |
CA2247009C (en) * | 1996-03-21 | 2009-08-04 | Imperial College Of Science, Technology And Medicine | Cryptic peptides and method for their identification |
DE19713001A1 (de) | 1997-03-27 | 1998-10-01 | Merck Patent Gmbh | Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung |
US6143496A (en) | 1997-04-17 | 2000-11-07 | Cytonix Corporation | Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly |
AU743647B2 (en) | 1998-01-31 | 2002-01-31 | Mt. Sinai School Of Medicine Of New York University | Methods and reagents for decreasing allergic reactions |
US7879977B2 (en) | 1998-01-31 | 2011-02-01 | University Of Arkansas | Methods and reagents for decreasing clinical reaction to allergy |
GB9930616D0 (en) | 1999-12-24 | 2000-02-16 | Mathilda & Terence Kennedy Ins | Activation and inhibition of the immune system |
US8153414B2 (en) | 2000-04-06 | 2012-04-10 | Allertein Therapeutics, Llc | Microbial delivery system |
US8246945B2 (en) | 2000-04-06 | 2012-08-21 | University Of Arkansas | Methods and reagents for decreasing clinical reaction to allergy |
JP2004522432A (ja) | 2000-12-22 | 2004-07-29 | シノヴィス・リミテッド | Toll関連レセプター(trr)シグナル伝達の調節方法 |
WO2004108753A1 (en) | 2003-06-10 | 2004-12-16 | The University Of Melbourne | Immunomodulating compositions, uses therefor and processes for their production |
CA2542332C (en) | 2003-10-16 | 2013-03-12 | Stephen John Ralph | Immunomodulating compositions and uses therefor |
GB0402131D0 (en) | 2004-01-30 | 2004-03-03 | Isis Innovation | Delivery method |
JP2010505883A (ja) | 2006-10-12 | 2010-02-25 | ザ ユニバーシティー オブ クイーンズランド | 免疫応答を調節するための組成物および方法 |
GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
BRPI0815395A2 (pt) | 2007-08-15 | 2015-02-10 | Circassia Ltd | Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição. |
US9220678B2 (en) | 2007-12-24 | 2015-12-29 | The University Of Queensland | Coating method |
CN102007066B (zh) | 2008-02-07 | 2013-06-26 | 昆士兰大学 | 贴片制造 |
EP2294415A4 (en) | 2008-05-23 | 2011-10-05 | Univ Queensland | ANALYTIC DETECTION BY MEANS OF MICRONADELPFLASTER WITH ANALYTICAL REAGENT |
GB0821806D0 (en) * | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
CN102325563A (zh) | 2008-12-22 | 2012-01-18 | 昆士兰大学 | 贴剂制备 |
US9943673B2 (en) | 2010-07-14 | 2018-04-17 | Vaxxas Pty Limited | Patch applying apparatus |
WO2012058715A1 (en) | 2010-11-01 | 2012-05-10 | University Of Technology, Sydney | Immune-modulating agents and uses therefor |
US8609621B2 (en) | 2010-11-15 | 2013-12-17 | E I Du Pont De Nemours And Company | Acid-cleavable linkers exhibiting altered rates of acid hydrolysis |
EP4233839A3 (en) | 2011-10-12 | 2023-09-27 | Vaxxas Pty Limited | Delivery device |
EP4218892A1 (en) | 2015-02-02 | 2023-08-02 | Vaxxas Pty Limited | Microprojection array applicator |
WO2017045031A1 (en) | 2015-09-18 | 2017-03-23 | Vaxxas Pty Limited | Microprojection arrays with microprojections having large surface area profiles |
EP3606760B1 (en) | 2017-03-31 | 2023-09-27 | Vaxxas Pty Limited | Device and method for coating surfaces |
AU2018285954A1 (en) | 2017-06-13 | 2019-12-19 | Vaxxas Pty Limited | Quality control of substrate coatings |
WO2019023757A1 (en) | 2017-08-04 | 2019-02-07 | Vaxxas Pty Limited | COMPACT MECHANICAL HIGH ENERGY STORAGE ACTUATOR WITH LOW TRIGGER STRENGTH FOR ADMINISTRATION OF MICROPROJECTION NETWORK (PRM) PATCHES |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4163778A (en) * | 1978-05-04 | 1979-08-07 | The Foundation for the Study of Asthma and Related Diseases | Asthma immunotherapy |
-
1990
- 1990-11-02 DE DE69033949T patent/DE69033949T2/de not_active Expired - Lifetime
- 1990-11-02 JP JP51589090A patent/JP3251012B2/ja not_active Expired - Lifetime
- 1990-11-02 WO PCT/US1990/006548 patent/WO1991006571A1/en active IP Right Grant
- 1990-11-02 ES ES91900596T patent/ES2174822T3/es not_active Expired - Lifetime
- 1990-11-02 DK DK91900596T patent/DK0500785T3/da active
- 1990-11-02 AU AU67330/90A patent/AU650249B2/en not_active Ceased
- 1990-11-02 CA CA002073045A patent/CA2073045C/en not_active Expired - Lifetime
- 1990-11-02 EP EP91900596A patent/EP0500785B1/en not_active Expired - Lifetime
- 1990-11-02 AT AT91900596T patent/ATE216401T1/de not_active IP Right Cessation
-
1992
- 1992-04-30 NO NO92921697A patent/NO921697L/no unknown
- 1992-04-30 FI FI921979A patent/FI921979A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69033949T2 (de) | 2002-11-14 |
DE69033949D1 (de) | 2002-05-23 |
CA2073045C (en) | 2007-05-22 |
EP0500785A1 (en) | 1992-09-02 |
WO1991006571A1 (en) | 1991-05-16 |
EP0500785B1 (en) | 2002-04-17 |
JPH05502445A (ja) | 1993-04-28 |
DK0500785T3 (da) | 2002-08-19 |
ES2174822T3 (es) | 2002-11-16 |
AU6733090A (en) | 1991-05-31 |
NO921697D0 (no) | 1992-04-30 |
CA2073045A1 (en) | 1991-05-04 |
AU650249B2 (en) | 1994-06-16 |
ATE216401T1 (de) | 2002-05-15 |
FI921979A (fi) | 1992-04-30 |
JP3251012B2 (ja) | 2002-01-28 |
FI921979A0 (fi) | 1992-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO921697L (no) | Human-t-celle-reaktivt felint protein (trfp) isolert fra husstoev, samt anvendelse derav | |
ATE449965T1 (de) | Diagnostisches und therapeutisches epitop | |
AU3192889A (en) | T cell activation markers | |
Mundy et al. | Big and little forms of osteoclast activating factor | |
FI941757A (fi) | Dermatofagoideista (talopölypunkki) peräisin olevien pääallergeenien T-soluepitoopit | |
HK1022918A1 (en) | Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna | |
ATE198754T1 (de) | Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung | |
SE9002589L (sv) | Neutrofil-aktiverande peptid-2 | |
ES2194838T3 (es) | Enlazadores peptidicos ricos en serina. | |
CA2053924C (en) | Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics | |
EP0284587A3 (en) | Synthetic peptide antigens for the detection of hiv-1 infection | |
AU626636B2 (en) | Pancreatic islet cell antigens obtained by molecular cloning | |
Thomas et al. | Fibronectin tetrapeptide is target for syphilis spirochete cytadherence. | |
WO1991008220A1 (en) | A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines | |
SE8902148L (sv) | Syntetiska peptid antigen foer detektion av htlv-1 infektion | |
ATE151882T1 (de) | Karzinomverwandtes haptoglobin (hpr) | |
JO1671B1 (en) | New ways to diagnose tuberculosis | |
DE3785664T2 (de) | Pertussis-toxin-polypeptid und seine applikationen. | |
SE9002212D0 (sv) | Igg binding protein | |
WO1992021697A3 (en) | Diagnostic peptides derived from m.tuberculosis antigens | |
HK1014547A1 (en) | Rabbit hemorrhagic disease virus (rhdv) recombinant capsids and proteins, diagnostic kits and vaccines containing them. | |
NO950526L (no) | T-celleepitoper av raigresspollen-allergen | |
GB9401689D0 (en) | Diagnosis and treatment of endocarditis | |
Onozaki et al. | Production of an antibody against guinea pig MIF: II. Analysis of the antibody-reacting material using radiolabeled lymphokines | |
EP0662150A4 (en) | MASPIN, NEW SERPIN WITH ANTI-TUMOR ACTIVITY. |